Lynn Gold
General Counsel bei IPI LEGACY LIQUIDATION CO
Aktive Positionen von Lynn Gold
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IPI LEGACY LIQUIDATION CO | General Counsel | 01.07.2018 | - |
Karriereverlauf von Lynn Gold
Ehemalige bekannte Positionen von Lynn Gold
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Camargo Pharmaceutical Services LLC
Camargo Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services Camargo Pharmaceutical Services LLC provides contract drug development, formulation, testing and regulatory consulting services. The company was founded by Kenneth V. Phelps and Ruth E. Stevens in 2003 and is headquartered in Cincinnati, OH. | Corporate Officer/Principal | - | 01.06.2010 |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Lynn Gold
Rochester Christian University | Doctorate Degree |
State University of New York at Buffalo | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Corporate Officer/Principal | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
IPI LEGACY LIQUIDATION CO | Health Technology |
Private Unternehmen | 2 |
---|---|
Camargo Pharmaceutical Services LLC
Camargo Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services Camargo Pharmaceutical Services LLC provides contract drug development, formulation, testing and regulatory consulting services. The company was founded by Kenneth V. Phelps and Ruth E. Stevens in 2003 and is headquartered in Cincinnati, OH. | Commercial Services |
Sonus Pharmaceuticals, Inc.
Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Health Technology |